Blood biomarkers
A1AT, neuronal injury
DYSFUNCTION
No differences were observed between the two arms concerning individual biomarker concentrations. Biomarkers in the plasma of both treatments did not indicate any possible neuronal injury or dysfunction at baseline. In comparison to normal sociodemographic ranges, the expressions were as follows: (1) normal: NfL, DA, PEDF; (2) elevated: BDNF, CC4, cystatin c and (3) low: pre-albumin, RANTES, ApoC3, AGP, A1AT and ICAM-1.